Unraveling the role of HER2 mutant alleles in breast cancer
A new editorial paper was published in Oncotarget's Volume 14 on October 31, 2023, entitled, "The uncharted role of HER2 mutant alleles in breast cancer."
Stay updated with breaking news from Bora Lim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new editorial paper was published in Oncotarget's Volume 14 on October 31, 2023, entitled, "The uncharted role of HER2 mutant alleles in breast cancer."
A new survey found that most adults don't recognize common breast cancer symptoms, aside from a lump in the breast. Because lumps can take time to develop, experts stress the importance of knowing all the symptoms associated with breast cancer, to best recognize the disease in the earliest stages.
A new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine and Baylor College of Medicine has created the world's largest and most comprehensive map of normal breast tissue, providing an unprecedented understanding of mammary biology that may help identify therapeutic targets for diseases such as breast cancer.
Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable.